Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Mar 4;45(3):666–673. doi: 10.2337/dc21-1520

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 by the American Diabetes Association

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/journals/pages/license.

PMC Copyright notice

Plasma metabolic profiles among patients with DM with and without CVD and the control group using PCA and each metabolite related with the risk of CVD in patients with diabetes. A: The score plots show a statistically significant difference in data between the DM and NGT groups, indicating significant biochemical changes caused by hyperglycemia. Furthermore, there was a clear separation between DM_CVD and DM_non-CVD, indicating that metabolites can differentiate diabetes with and without CVD. B: Association between each metabolite and CVD in diabetes after adjustment for age, sex, smoking, BMI, SBP, FPG, and TC. PC, glycerophosphocholine. ‡Per 0.01-unit increase; §per 0.1-unit increase; ǁper 10-unit increase.